Cutting-Edge Drug Delivery and Nanomedicine: Innovations in Hybrid Systems, Theranostics and Targeted Therapies

Dear Colleagues,

This Special Issue aims to highlight the latest advancements in drug delivery systems and nanomedicine, focusing on innovative strategies that enhance therapeutic efficacy and precision in the treatment of complex conditions such as cancer and infectious diseases, among others. This Special Issue will cover a wide range of topics, including cutting-edge approaches to drug and protein delivery, the development of nanoparticles, and the use of nanoeffectors in photodynamic (PDT) and photothermal therapy (PTT). Emphasis will be placed on hybrid systems that integrate diverse strategies, such as polymeric, lipidic, and other combinatory approaches, to optimize delivery pathways and improve therapeutic outcomes. Additionally, this Special Issue will delve into targeted therapies designed to selectively engage disease sites, minimizing off-target effects and maximizing therapeutic potential, as well as theragnostic approaches that combine therapeutic and diagnostic capabilities. Furthermore, strategies for drug repurposing in the development of novel nanomedicines for alternative therapies will be included. Various administration routes, including oral, topical, intravenous, pulmonary, and localized delivery, will also be explored. This edition seeks to bring together pioneering research that is redefining the landscape of modern medicine through the integration of advanced materials and multidisciplinary approaches.

Dr. Maria Natalia Calienni
Dr. Marcela Analia Moretton
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.